Surgery is the mainstay treatment for endometrial cancer and complex atypical endometrial hyperplasia. These conditions are more common in the obese women and as such these patients pose additional risks and challenges to surgery. Laparoscopic hysterectomy (LH) is preferred over open surgery in obese patients as it reduces surgical morbidity. However, more recently, robotic-assisted hysterectomy (RH) has been used in morbidly obese patients to overcome the limitations of conventional laparoscopy. To compare the surgical outcomes of morbidly obese patients undergoing LH or RH for endometrial cancer or complex atypical hyperplasia. A retrospective analysis of morbidly obese patients (BMI > 40 kg/m2) who underwent LH or RH for endometrial cancer or complex atypical hyperplasia at the Chris O’Brien Lifehouse Gynaecological Oncology Unit from 2015 to 2019 was performed. Data was collected from the prospectively maintained gynaecology oncology database and descriptive analysis was performed. 33 (51.6%) underwent LH and 31 (48.4%) had RH. More LHs were performed 2015–2017 period, whereas there were more RHs performed in 2018–2019 period (p = 0.01). The difference between theatre time use and operating time for LH surgery compared to RH was significantly shorter (45.7 for LH versus 61.9 min for RH, p = 0.009). RH was performed more commonly when BMI was > 50 kg/m2 (p = 0.02). There has been an increase in the use of RH in morbidly obese patients, particularly for women with a BMI > 50 kg/m2.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Availability of data and material
All relevant data are available.
Endometrial cancer statistics. Australian Government. [Cited 20/12/2019]. https://endometrial-cancer.canceraustralia.gov.au/statistics. Accessed 20 Dec 2019
Mills AM, Longacre TA (2010) Endometrial hyperplasia. Semin Diagn Pathol 27:199–214
Laaksonen MA, Arriaga ME, Canfell K, MacInnis RJ, Byles JE, Banks E, Shaw JE, Mitchell P, Giles GG, Magliano DJ, Gill TK, Klaes E, Velentzis LS, Hirani V, Cumming RG, Vajdic CM (2019) The preventable burden of endometrial and ovarian cancers in Australia: a pooled cohort study. Gynecol Oncol 153(3):580–588
A picture of overweight and obesity in Australia 2017. Australian Institute of Health and Welfare. [Cited 22/1/2020]. https://www.aihw.gov.au/getmedia/45f6ecc6-0caf-4af4-9ffc-a44c885b33d2/aihw-phe-216.pdf.aspx?inline=true. Accessed 22 Jan 2020
Chan JK, Gardner AB, Taylor K, Thompson CA, Blansit K, Yu X, Kapp DS (2015) Robotic versus laparoscopic versus open surgery in morbidly obese endometrial cancer patients—a comparative analysis of total charges and complication rates. Gynecol Oncol 139(2):300–305
Calle EE, Rodriquez C, Walker-Thurmond K et al (2003) Overweight, obesity and mortality from cancer in prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638
Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF (2008) What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? Gynecol Oncol 111(1):41–45
Janda M, Gebski V, Forder P et al (2006) Total laparoscopic versus open surgery for stage 1 endometrial cancer: the LACE randomized controlled trial. Contemp Clin Trials 27:353–363
Janda M, Gebski V, Davies LC et al (2017) Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage i endometrial cancer: a Randomized Clinical Trial. JAMA 317(12):1224–1233
Agha R, Muir G (2003) Does laparoscopic surgery spell the end of the open surgeon? J R Soc Med 96(11):544–546
Lamvu G, Zolnoun D, Boggess J, Steege JF (2004) Obesity: physiologic changes and challenges during laparoscopy. Am J Obstet Gynecol 191:669–674
daVinci Systems. Cited 22/1/2020. Available from: https://www.intuitive.com/en-us/products-and-services/da-vinci/systems. Accessed 22 Jan 2020
Committee opinion no (2015) 628: robotic surgery in gynecology. Obstet Gynecol 125:760–767
Committee on Gynecologic Practice (2015) Committee opinion no. 619: gynecologic surgery in the obese woman. Obstet Gynecol 125:274–278
Kakde AS, Wagh HD (2017) An observational study: effects of tenting of the abdominal wall on peak airway pressure in robotic radical prostatectomy surgery. Saudi J Anaesth 11:279–282
Leitao MM, Narain WR, Boccamazzo D et al (2016) Impact of robotic platforms on surgical approach and costs in the management of morbidly obese patients with newly diagnosed uterine cancer. Ann Surg Oncol 23(7):2192–2198
Seaman LG, Cohn DE, Richardson DL, Valmadre S, Carlson MJ, Phillips GS, Fowler JM (2008) Robotic hysterectomy and pelvic- aortic lymphadenectomy for endometrial cancer. Obstet Gynecol 112(6):1207–1213
Lau S, Buzaglo K, Vaknin Z et al (2011) Relationship between body mass index and robotic surgery outcomes of women diagnosed with endometrial cancer. Int J Gynecol Cancer 21:722–729
Bernardini MQ, Gien LT, Tipping H, Murphy J, Rosen BP (2012) Surgical outcome of robotic surgery in morbidly obese patient with endometrial cancer compared to laparotomy. Int J Gynecol Cancer 22:76–81
Stephan J, Goodheart MJ, McDonald M, Hansen J, Reyes HD, Button A, Bender D (2015) Robotic surgery in supermorbidly obese patients with endometrial cancer. Am J Obstet Gynecol 213(1):49.e1–49.e8
Cusimano MC, Simpson AN, Dossa F et al (2019) Laparoscopic and robotic hysterectomy in endometrial cancer patients with obesity: a systematic review and meta-analysis of conversions and complications. Am J Obstet Gynecol 221(5):410–428.e19
Walker JL, Piedmonte MR, Spirtos NM et al (2009) Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic Oncology Group Study LAP2. J Clin Oncol 27:5331–5336
Oehler MK (2011) Robotic surgery in gynaecology and gynaecological oncology: Program initiation and operative outcomes at the. Aust NZ J Obstet and Gynaecol 51:119–124
Nightingale CE, Margarson MP, Shearer E et al (2015) Peri-operative management of the obese surgical patient 2015. Anaesthesia 70(7):859–876
Wright JD, Ananth CV, Lewin SN et al (2013) Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA 309(7):689–698
Cardenas-Goicoechea J, Adams S, Bhat SB, Randall TC (2010) Surgical outcomes of robotic-assisted surgical staging for endometrial cancer are equivalent to traditional laparoscopic staging at a minimally invasive surgical center. Gynecol Oncol 117(2):224–228
Sarlos D, Kots L, Stevanovic N, Schaer G (2010) Robotic hysterectomy versus conventional laparoscopic hysterectomy: outcome and cost analyses of a matched case-control study. Eur J Obstet Gynecol Reprod Biol 150(1):92–96
No funding was obtained to conduct this research.
Conflict of interest
Vanessa El-Achi, Jennifer Weishaupt, Jonathan Carter and Sam Saidi declare that they have no conflict of interest.
This retrospective study involving human participants was in accordance with the ethical standards of the institutional and national research standards, and in line with the principles of the Declaration of Helsinki. Ethics approval was obtained from the Sydney Local Health District and Chris O’Brien Lifehouse (X19-099 & 2019/ETH13958, LH19.058).
Informed consent was obtained from all individual participants included in the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Research was carried out at in the Gynaecology Oncology Department at Chris O’Brien Lifehouse, Sydney, Australia.
About this article
Cite this article
El-Achi, V., Weishaupt, J., Carter, J. et al. Robotic versus laparoscopic hysterectomy in morbidly obese women for endometrial cancer. J Robotic Surg (2020). https://doi.org/10.1007/s11701-020-01133-z
- Robotic-assisted surgery
- Minimally invasive surgery
- Endometrial cancer
- Endometrial hyperplasia